These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10201475

  • 1. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
    Lin HC, Hou MC, Lee WC, Huang YT, Lee FY, Chang FY, Tsai YT, Lee SD.
    Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McIntyre N, Burroughs AK.
    Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
    [Abstract] [Full Text] [Related]

  • 3. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 4. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK, Jeong PH, Ji SW, Yoo BS, Kim HS, Lee DK, Kwon SO, Kim YJ, Park JW, Chang SJ, Lee SS.
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 7. Effects of octreotide on postprandial systemic and hepatic hemodynamics in patients with postnecrotic cirrhosis.
    Lin HC, Tsai YT, Huang CC, Meng HC, Lee FY, Wang SS, Lee SD, Lo KJ.
    J Hepatol; 1994 Sep; 21(3):424-9. PubMed ID: 7836713
    [Abstract] [Full Text] [Related]

  • 8. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [Abstract] [Full Text] [Related]

  • 9. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV.
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 11. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy].
    Lu SC, Meng FK, Ding HG, Zhang JG, Ding L, Wang SZ.
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266
    [Abstract] [Full Text] [Related]

  • 12. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, Amodio P, Sticca A, Caregaro L, Maffei-Faccioli A, Gatta A.
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [Abstract] [Full Text] [Related]

  • 13. [Changes in hemodynamics and nitric oxide/endothelin-1 during liver transplantation in patients with cirrhosis].
    Hei ZQ, Luo CF, Li SR, Ma WH, Luo GJ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):592-4. PubMed ID: 16259914
    [Abstract] [Full Text] [Related]

  • 14. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
    Westphal M, Stubbe H, Sielenkämper AW, Ball C, Van Aken H, Borgulya R, Bone HG.
    Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
    [Abstract] [Full Text] [Related]

  • 15. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation.
    Tietge UJ, Bahr MJ, Manns MP, Böker KH.
    Liver Transpl; 2001 Dec; 7(12):1015-22. PubMed ID: 11753903
    [Abstract] [Full Text] [Related]

  • 16. [Effects of denopamine on hemodynamics and blood gases in secondary pulmonary hypertension].
    Ido A, Tsuji T, Shimizu T, Fukuzawa J, Fujiuchi S, Fujita Y, Ohki Y, Sasaki N, Sakai E, Onodera S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1553-9. PubMed ID: 1808377
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Lee SD, Hsia HC, Lin WJ, Lo KJ.
    Gastroenterology; 1992 Jul; 103(1):229-34. PubMed ID: 1612330
    [Abstract] [Full Text] [Related]

  • 18. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic variations during thoracic and abdominal stop-flow regional chemotherapy.
    Varrassi G, Guadagni S, Ciccozzi A, Marinangeli F, Pozone T, Piroli A, Marsili I, Paladini A.
    Eur J Surg Oncol; 2004 May; 30(4):377-83. PubMed ID: 15063890
    [Abstract] [Full Text] [Related]

  • 20. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.